Literature DB >> 23467018

Refinement of the ECETOC approach to identify endocrine disrupting properties of chemicals in ecotoxicology.

Lennart Weltje1, James R Wheeler, Arnd Weyers, Malyka Galay-Burgos.   

Abstract

To use and implement an assessment scheme for the evaluation of endocrine disrupting properties of chemicals in ecotoxicology, the types of effect need to be agreed. Effects that merit further consideration in this context should fulfil the following three criteria: caused by an endocrine mode of action, be adverse, and be relevant at the population level to reflect the protection goal of ecotoxicological assessments. Thereafter, a comparison of effect values, regardless of the causative mechanisms, should be made, firstly to determine if endocrine toxicity generates the lowest endpoint within a taxon, and secondly if it is the lowest endpoint compared to that of other taxa living in the same compartment. These comparisons inform on two levels of specificity and determine if endocrine-mediated side-effects determine the ecotoxicological profile of a chemical. Various quantitative measures for the assessment of potency are also presented, which could assist in determining how to handle substances in the risk assessment when a regulatory concern is identified. Finally, derogation criteria should be defined for compounds that were designed as endocrine disruptors for non-vertebrates and those for which there is 'negligible exposure'. This paper discusses and provides proposals on how to apply these concepts for assessment of substances.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adversity; Endocrine disruption; Population relevance; Risk assessment; Specificity

Mesh:

Substances:

Year:  2013        PMID: 23467018     DOI: 10.1016/j.toxlet.2013.02.019

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  1 in total

1.  Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances.

Authors:  Peter Matthiessen; Gerald T Ankley; Ronald C Biever; Poul Bjerregaard; Christopher Borgert; Kristin Brugger; Amy Blankinship; Janice Chambers; Katherine K Coady; Lisa Constantine; Zhichao Dang; Nancy D Denslow; David A Dreier; Steve Dungey; L Earl Gray; Melanie Gross; Patrick D Guiney; Markus Hecker; Henrik Holbech; Taisen Iguchi; Sarah Kadlec; Natalie K Karouna-Renier; Ioanna Katsiadaki; Yukio Kawashima; Werner Kloas; Henry Krueger; Anu Kumar; Laurent Lagadic; Annegaaike Leopold; Steven L Levine; Gerd Maack; Sue Marty; James Meador; Ellen Mihaich; Jenny Odum; Lisa Ortego; Joanne Parrott; Daniel Pickford; Mike Roberts; Christoph Schaefers; Tamar Schwarz; Keith Solomon; Tim Verslycke; Lennart Weltje; James R Wheeler; Mike Williams; Jeffrey C Wolf; Kunihiko Yamazaki
Journal:  Integr Environ Assess Manag       Date:  2017-01-27       Impact factor: 2.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.